Boreal Genomics Developing Sequence-Enrichment Tech as DNA Purification Platform Nears Market

Boreal's prototype platform can differentiate and enrich for sequences that differ by one nucleotide from as many as 10,000 copies of background DNA. The company believes it has potential for use in clinical applications.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.